Thinking beyond the benchtop instrument in CRISPR, Covid Surveillance and Cancer Research workflows

13 JULY 23 | 2:30 PM BST

Automata Technologies

Join Jerome Nicod, Head of the Advanced Sequencing Facility (ASF) at the Francis Crick Institute in a discussion on how automation can unlock a step change in the potential of genomics labs. 

We’ll do a deep dive into how, with Automata’s solution, the ASF is parallelising multiple workflows to optimise flexibility, throughput and reliability:

  • Amplicon Library Preparation – an assay requiring rapid turnaround time, typically for validation of CRISPR modifications by sequencing; 
  • FFPE RNA Extraction – the process of extracting RNA from formalin-fixed paraffin-embedded tissues; 
  • COVID-19 Sequencing – the globally-used ARTIC protocol to prepare samples for the sequencing of SARS-CoV-2 genomes

Our speakers

Jerome Nicod, Head of the Advanced Sequencing Facility
Science Technology Platform, Francis Crick Institute

Jérôme joined the Crick in April 2018 as Head of the Advanced Sequencing Facility.

He holds a degree in pharmacy from the University of Lausanne and a PhD with a focus on genetics from the University of Bern.

Before joining the Crick he held a variety of roles across research and management projects including working on the language-related gene FOXP2 and leading a large-scale international project looking at the genetics of complex traits in the mouse, with a particular interest in behaviour.

Divya Vijay Pratheek, Product Growth Director, Genomics

Divya is Director of Product Growth for Multiomics at Automata where she leads the strategy, development and growth of multi-omics applications on the Automata platform.

After obtaining a BSc in Microbiology in India, she went on to achieve a MSc in Communication and Media Studies in the US, before embarking on an extensive career in global product management and growth across the biotechnology sector in Germany and the UK.

About the Francis Crick Institute

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.

The major benefit of our walkaway workflows developed by Automata is the ability to prepare samples and generate data rapidly, accelerating the pace of discoveries at the Crick.
Jerome Nicod, Head of the Advanced Sequencing Facility at the Francis Crick Institute

About Automata

Automata is the leading robotics and automation company powering the laboratories of the future. Our automated technology enables new and improved processes, empowers scientists with transformed ways of working and delivers faster translation of results from ‘bench to bedside’. Our Lab Automation Platform meets labs where they are on their automation journey, and we are the trusted partner to improving efficiencies and freeing scientists to work on new and innovative discoveries.   

We are trusted by customers including trusts within the NHS, and are supporting advancements across Core Testing Labs, Academic Institutes, CDMOs, Pharmas and Biotechs.